Andreas Reis

Biographic Data

ID4485123
NAMEAndreas Reis
GIVEN NAMESAndreas
FAMILY NAMEReis
SIGNATUREREIS A
AFFILIATIONSWorld Health Organization
ORCID0000-0002-8218-2615
VERIFIEDYes
TOTAL WORKS7
TOTAL CITATIONS0
AUTHOR COUNT6
EDITOR COUNT1
FIRST PUBLICATION YEAR2021
LATEST PUBLICATION YEAR2026
H-INDEX0

  • Governance Structures for Health Research Ethics in the Eastern Mediterranean Region

    Open AccessAhmed Mandil, Arash Rashidian et al.ARTICLEJournal of Empirical Research on…2026

    IntroductionThis work aimed at mapping research ethics governance at EMR countries.MethodsThe study used two tools shared with Eastern Mediterranean Region (EMR) countries. The first enquired about legal provisions and regulatory frameworks, as well as Research Ethics Committee (REC) composition, resources, procedures. The second covered ethical oversight of clinical trials (CTs), including coordination of ethical reviews.ResultsMost respondents …

  • How will ‘Chat-IRB’ impact research ethics review in LMICs

    Keymanthri Moodley, Rohit Malpani et al.ARTICLEJournal of Medical Ethics2025

    While the use of generative artificial intelligence (AI) in research has sparked controversy internationally, the use of large language models (LLMs) in the ethics review of research protocols is particularly contentious. Against this backdrop, Porsdam Mann et al recently published a comprehensive, well-balanced and carefully considered paper on the use of application-specific LLMs by Research Ethics Committees (RECs). Although we support the pot…

  • Pandemics and Ethics

    Open AccessAndreas Reis, Martina Schmidhuber et al.BOOKPandemics and Ethics2023

    The book provides guidance to policymakers, physicians, nurses & interested laypersons on how to deal with difficult ethical issues in epidemics/pandemics.

  • Ethical priorities for international collaborative adaptive platform trials for public health emergencies

    Open AccessKatharine Wright, Joseph Ali et al.ARTICLEBMJ Global Health2023

    Rapidly produced evidence on effective medical counter measures is critical for responding to health emergencies caused by (re-)emerging infectious diseases. Adaptive platform trials played a significant role in the global research response to COVID-19 and are likely to be increasingly used in the future, both in emergency and non-emergency contexts. We call attention to a number of ethical considerations that should influence the development and…

  • Pandemics and Ethics

    Andreas Reis, Martina Schmidhuber et al.BOOKPandemics and Ethics2023

  • Ethical implications of economic compensation for voluntary medical male circumcision for HIV prevention and epidemic control

    Open AccessJohannes Kohler, Jerome Amir Singh et al.ARTICLEPLOS Global Public Health2022

    Despite tremendous efforts in fighting HIV over the last decades, the estimated annual number of new infections is still a staggering 1.5 million. There is evidence that voluntary medical male circumcision (VMMC) provides protection against men’s heterosexual acquisition of HIV-1 infection. Despite good progress, most countries implementing VMMC for HIV prevention programmes are challenged to reach VMMC coverage rates of 90%. Particularly for men…

  • Leveraging artificial intelligence to assist the ethical and science-based distribution of Covid-19 vaccines

    Open AccessSheng Wu, Andreas Reis et al.ARTICLEJournal of Global Health2021

    While the COVID-19 vaccines are rolling out globally, the battle against COVID-19 has reached a breaking point, where 'decisions made by leaders and citizens will determine when the acute phase of the pandemic will end' [1].Artificial intelligence (AI) can assist in transforming the conventional decision-making model and assist science-based and ethical distribution of the vaccine.To ensure timely administration of the vaccine, many countries and…